Keywords
Last Name
Institution

Barry S. Rosenstein

TitlePROFESSOR
InstitutionMount Sinai
DepartmentRadiation Oncology
Address
    Other Positions
    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentGenetics and Genomic Sciences

    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentDermatology

    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentPreventive Medicine


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kerns SL, Stock RG, Stone NN, Blacksburg SR, Rath L, Vega A, Fachal L, Gómez-Caamaño A, De Ruysscher D, Lammering G, Parliament M, Blackshaw M, Sia M, Cesaretti J, Terk M, Hixson R, Rosenstein BS, Ostrer H. Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer. Radiother Oncol. 2013 Jun; 107(3):372-6.
      View in: PubMed
    2. Kerns SL, Stone NN, Stock RG, Rath L, Ostrer H, Rosenstein BS. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer. J Urol. 2013 Jul; 190(1):102-8.
      View in: PubMed
    3. Barnett GC, Elliott RM, Alsner J, Andreassen CN, Abdelhay O, Burnet NG, Chang-Claude J, Coles CE, Gutiérrez-Enríquez S, Fuentes-Raspall MJ, Alonso-Muñoz MC, Kerns S, Raabe A, Symonds RP, Seibold P, Talbot CJ, Wenz F, Wilkinson J, Yarnold J, Dunning AM, Rosenstein BS, West CM, Bentzen SM. Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. Radiother Oncol. 2012 Dec; 105(3):289-95.
      View in: PubMed
    4. Fu S, Yang Y, Das TK, Yen Y, Zhou BS, Zhou MM, Ohlmeyer M, Ko EC, Cagan R, Rosenstein BS, Chen SH, Kao J. Correction: ?-H2AX Kinetics as a Novel Approach to High Content Screening for Small Molecule Radiosensitizers. PLoS One. 2012; 7(9).
      View in: PubMed
    5. Kerns SL, Stock R, Stone N, Buckstein M, Shao Y, Campbell C, Rath L, De Ruysscher D, Lammering G, Hixson R, Cesaretti J, Terk M, Ostrer H, Rosenstein BS. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Jan 1; 85(1):e21-8.
      View in: PubMed
    6. Fu S, Yang Y, Das TK, Tirtha D, Yen Y, Zhou BS, Zhou MM, Ohlmeyer M, Ko EC, Cagan R, Rosenstein BS, Chen SH, Kao J. ?-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizers. PLoS One. 2012; 7(6):e38465.
      View in: PubMed
    7. Raza S, Lymberis SC, Ciervide R, Axelrod D, Fenton-Kerimian M, Magnolfi C, Rosenstein B, Dewyngaert JK, Formenti SC. Comparison of Acute and Late Toxicity of Two Regimens of 3- and 5-Week Concomitant Boost Prone IMRT to Standard 6-Week Breast Radiotherapy. Front Oncol. 2012; 2:44.
      View in: PubMed
    8. West CM, Dunning AM, Rosenstein BS. Genome-wide association studies and prediction of normal tissue toxicity. Semin Radiat Oncol. 2012 Apr; 22(2):91-9.
      View in: PubMed
    9. Kelsey CR, Rosenstein BS, Marks LB. Predicting toxicity from radiation therapy--it's genetic, right? Cancer. 2012 Jul 15; 118(14):3450-4.
      View in: PubMed
    10. Ko EC, Forsythe K, Buckstein M, Kao J, Rosenstein BS. Radiobiological rationale and clinical implications of hypofractionated radiation therapy. Cancer Radiother. 2011 Jun; 15(3):221-9.
      View in: PubMed
    11. Cuaron JJ, Hirsch AE, Medich DC, Hirsch JA, Rosenstein BS. Introduction to radiation safety and monitoring. J Am Coll Radiol. 2011 Apr; 8(4):259-64.
      View in: PubMed
    12. Rosenstein BS. Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapy. Pharmacogenomics. 2011 Feb; 12(2):267-75.
      View in: PubMed
    13. Stone NN, Stone MM, Rosenstein BS, Unger P, Stock RG. Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy. J Urol. 2011 Feb; 185(2):495-500.
      View in: PubMed
    14. Kerns SL, Ostrer H, Stock R, Li W, Moore J, Pearlman A, Campbell C, Shao Y, Stone N, Kusnetz L, Rosenstein BS. Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Dec 1; 78(5):1292-300.
      View in: PubMed
    15. West C, Rosenstein BS, Alsner J, Azria D, Barnett G, Begg A, Bentzen S, Burnet N, Chang-Claude J, Chuang E, Coles C, De Ruyck K, De Ruysscher D, Dunning A, Elliott R, Fachal L, Hall J, Haustermans K, Herskind C, Hoelscher T, Imai T, Iwakawa M, Jones D, Kulich C. Establishment of a Radiogenomics Consortium. Int J Radiat Oncol Biol Phys. 2010 Apr; 76(5):1295-6.
      View in: PubMed
    16. Bernstein JL, Haile RW, Stovall M, Boice JD, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH, Malone KE, Mellemkjaer L, Borresen-Dale AL, Rosenstein BS, Teraoka SN, Diep AT, Smith SA, Capanu M, Reiner AS, Liang X, Gatti RA, Concannon P. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst. 2010 Apr 7; 102(7):475-83.
      View in: PubMed
    17. Bentzen SM, Parliament M, Deasy JO, Dicker A, Curran WJ, Williams JP, Rosenstein BS. Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects. Int J Radiat Oncol Biol Phys. 2010 Mar 1; 76(3 Suppl):S145-50.
      View in: PubMed
    18. Azria D, Belkacemi Y, Romieu G, Gourgou S, Gutowski M, Zaman K, Moscardo CL, Lemanski C, Coelho M, Rosenstein B, Fenoglietto P, Crompton NE, Ozsahin M. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. Lancet Oncol. 2010 Mar; 11(3):258-65.
      View in: PubMed
    19. West C, Rosenstein BS. Establishment of a radiogenomics consortium. Radiother Oncol. 2010 Jan; 94(1):117-8.
      View in: PubMed
    20. Azria D, Ozsahin M, Rosenstein B. Radiation-induced sequelae measured by means of lymphocyte apoptosis: importance of certain single nucleotide polymorphisms: in regard to Schnarr et al. (Int J Radiat Oncol Biol Phys 2009). Int J Radiat Oncol Biol Phys. 2009 Nov 15; 75(4):1275; author reply 1275-6.
      View in: PubMed
    21. Stone NN, Cesaretti JA, Rosenstein B, Stock RG. Do high radiation doses in locally advanced prostate cancer patients treated with 103Pd implant plus external beam irradiation cause increased urinary, rectal, and sexual morbidity? Brachytherapy. 2010 Apr-Jun; 9(2):114-8.
      View in: PubMed
    22. Rosenstein BS, Held KD, Rockwell S, Williams JP, Zeman EM. American Society for Radiation Oncology (ASTRO) survey of radiation biology educators in U.S. and Canadian radiation oncology residency programs. Int J Radiat Oncol Biol Phys. 2009 Nov 1; 75(3):896-905.
      View in: PubMed
    23. Hirsch AE, Rosenstein BS, Medich DC, Martel CB, Hirsch JA. Polymethylmethacrylate and radioisotopes in vertebral augmentation: an explanation of underlying principles. Pain Physician. 2009 Sep-Oct; 12(5):887-91.
      View in: PubMed
    24. Cuaron JJ, Hirsch JA, Medich DC, Rosenstein BS, Martel CB, Hirsch AE. A proposed methodology to select radioisotopes for use in radionuclide therapy. AJNR Am J Neuroradiol. 2009 Nov; 30(10):1824-9.
      View in: PubMed
    25. Hou YN, Lavaf A, Huang D, Peters S, Huq R, Friedrich V, Rosenstein BS, Kao J. Development of an automated gamma-H2AX immunocytochemistry assay. Radiat Res. 2009 Mar; 171(3):360-7.
      View in: PubMed
    26. Azria D, Ozsahin M, Kramar A, Peters S, Atencio DP, Crompton NE, Mornex F, Pèlegrin A, Dubois JB, Mirimanoff RO, Rosenstein BS. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res. 2008 Oct 1; 14(19):6284-8.
      View in: PubMed
    27. Azria D, Belkacemi Y, Lagrange JL, Chapet O, Mornex F, Maingon P, Hennequin C, Rosenstein B, Ozsahin M. [Radiation-induced sequelae: toward an individual profile]. Cancer Radiother. 2008 Nov; 12(6-7):619-24.
      View in: PubMed
    28. Concannon P, Haile RW, Børresen-Dale AL, Rosenstein BS, Gatti RA, Teraoka SN, Diep TA, Jansen L, Atencio DP, Langholz B, Capanu M, Liang X, Begg CB, Thomas DC, Bernstein L, Olsen JH, Malone KE, Lynch CF, Anton-Culver H, Bernstein JL. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. Cancer Res. 2008 Aug 15; 68(16):6486-91.
      View in: PubMed
    29. Azria D, Rosenstein BS, Ozsahin M. Radiation-induced side effects with or without systemic therapies: prime time for prediction of individual radiosensitivity. Int J Radiat Oncol Biol Phys. 2008 Aug 1; 71(5):1293-4.
      View in: PubMed
    30. Burri RJ, Stock RG, Cesaretti JA, Atencio DP, Peters S, Peters CA, Fan G, Stone NN, Ostrer H, Rosenstein BS. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. Radiat Res. 2008 Jul; 170(1):49-59.
      View in: PubMed
    31. Stovall M, Smith SA, Langholz BM, Boice JD, Shore RE, Andersson M, Buchholz TA, Capanu M, Bernstein L, Lynch CF, Malone KE, Anton-Culver H, Haile RW, Rosenstein BS, Reiner AS, Thomas DC, Bernstein JL. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008 Nov 15; 72(4):1021-30.
      View in: PubMed
    32. Constantine C, Parhar P, Lymberis S, Fenton-Kerimian M, Han SC, Rosenstein BS, Formenti SC. Feasibility of accelerated whole-breast radiation in the treatment of patients with ductal carcinoma in situ of the breast. Clin Breast Cancer. 2008 Jun; 8(3):269-74.
      View in: PubMed
    33. Hirsch AE, Medich DC, Rosenstein BS, Martel CB, Hirsch JA. Radioisotopes and vertebral augmentation: dosimetric analysis of a novel approach for the treatment of malignant compression fractures. Radiother Oncol. 2008 Apr; 87(1):119-26.
      View in: PubMed
    34. Cesaretti JA, Pennathur A, Rosenstein BS, Swanson SJ, Fernando HC. Stereotactic radiosurgery for thoracic malignancies. Ann Thorac Surg. 2008 Feb; 85(2):S785-91.
      View in: PubMed
    35. Wang Y, Zhou X, Weinstein E, Maryles B, Zhang Y, Moore J, Gao D, Atencio DP, Rosenstein BS, Lebwohl M, Chen HD, Xiao T, Wei H. p53 gene mutations in SKH-1 mouse tumors differentially induced by UVB and combined subcarcinogenic benzo[a]pyrene and UVA. Photochem Photobiol. 2008 Mar-Apr; 84(2):444-9.
      View in: PubMed
    36. Peters CA, Stock RG, Cesaretti JA, Atencio DP, Peters S, Burri RJ, Stone NN, Ostrer H, Rosenstein BS. TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Mar 1; 70(3):752-9.
      View in: PubMed
    37. DeWyngaert JK, Jozsef G, Mitchell J, Rosenstein B, Formenti SC. Accelerated intensity-modulated radiotherapy to breast in prone position: dosimetric results. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1251-9.
      View in: PubMed
    38. Ho AY, Fan G, Atencio DP, Green S, Formenti SC, Haffty BG, Iyengar P, Bernstein JL, Stock RG, Cesaretti JA, Rosenstein BS. Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Nov 1; 69(3):677-84.
      View in: PubMed
    39. Cesaretti JA, Stock RG, Atencio DP, Peters SA, Peters CA, Burri RJ, Stone NN, Rosenstein BS. A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2007 Aug 1; 68(5):1410-6.
      View in: PubMed
    40. Formenti SC, Gidea-Addeo D, Goldberg JD, Roses DF, Guth A, Rosenstein BS, DeWyngaert KJ. Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol. 2007 Jun 1; 25(16):2236-42.
      View in: PubMed
    41. Hirsch AE, Atencio DP, Rosenstein BS. Screening for ATM sequence alterations in African-American women diagnosed with breast cancer. Breast Cancer Res Treat. 2008 Jan; 107(1):139-44.
      View in: PubMed
    42. Langholz B, Bernstein JL, Bernstein L, Olsen JH, Børresen-Dale AL, Rosenstein BS, Gatti RA. On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer. Int J Cancer. 2006 Aug 1; 119(3):724-5.
      View in: PubMed
    43. Ho AY, Atencio DP, Peters S, Stock RG, Formenti SC, Cesaretti JA, Green S, Haffty B, Drumea K, Leitzin L, Kuten A, Azria D, Ozsahin M, Overgaard J, Andreassen CN, Trop CS, Park J, Rosenstein BS. Genetic predictors of adverse radiotherapy effects: the Gene-PARE project. Int J Radiat Oncol Biol Phys. 2006 Jul 1; 65(3):646-55.
      View in: PubMed
    44. Newcomb EW, Lymberis SC, Lukyanov Y, Shao Y, Schnee T, Devitt M, Rosenstein BS, Zagzag D, Formenti SC. Radiation sensitivity of GL261 murine glioma model and enhanced radiation response by flavopiridol. Cell Cycle. 2006 Jan; 5(1):93-9.
      View in: PubMed
    45. Andreassen CN, Overgaard J, Alsner J, Overgaard M, Herskind C, Cesaretti JA, Atencio DP, Green S, Formenti SC, Stock RG, Rosenstein BS. ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Mar 1; 64(3):776-83.
      View in: PubMed
    46. Kao J, Rosenstein BS, Peters S, Milano MT, Kron SJ. Cellular response to DNA damage. Ann N Y Acad Sci. 2005 Dec; 1066:243-58.
      View in: PubMed
    47. Stock RG, Stone NN, Cesaretti JA, Rosenstein BS. Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results. Int J Radiat Oncol Biol Phys. 2006 Feb 1; 64(2):527-33.
      View in: PubMed
    48. Wang Y, Gao D, Atencio DP, Perez E, Saladi R, Moore J, Guevara D, Rosenstein BS, Lebwohl M, Wei H. Combined subcarcinogenic benzo[a]pyrene and UVA synergistically caused high tumor incidence and mutations in H-ras gene, but not p53, in SKH-1 hairless mouse skin. Int J Cancer. 2005 Aug 20; 116(2):193-9.
      View in: PubMed
    49. Cesaretti JA, Stock RG, Lehrer S, Atencio DA, Bernstein JL, Stone NN, Wallenstein S, Green S, Loeb K, Kollmeier M, Smith M, Rosenstein BS. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. Int J Radiat Oncol Biol Phys. 2005 Jan 1; 61(1):196-202.
      View in: PubMed
    50. Rosenstein BS, Lymberis SC, Formenti SC. Biologic comparison of partial breast irradiation protocols. Int J Radiat Oncol Biol Phys. 2004 Dec 1; 60(5):1393-404.
      View in: PubMed
    51. Formenti SC, Truong MT, Goldberg JD, Mukhi V, Rosenstein B, Roses D, Shapiro R, Guth A, Dewyngaert JK. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2004 Oct 1; 60(2):493-504.
      View in: PubMed
    52. Bernstein JL, Langholz B, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch CF, Olsen JH, Anton-Culver H, Shore RE, Boice JD, Berkowitz GS, Gatti RA, Teitelbaum SL, Smith SA, Rosenstein BS, Børresen-Dale AL, Concannon P, Thompson WD. Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res. 2004; 6(3):R199-214.
      View in: PubMed
    53. Bernstein JL, Bernstein L, Thompson WD, Lynch CF, Malone KE, Teitelbaum SL, Olsen JH, Anton-Culver H, Boice JD, Rosenstein BS, Børresen-Dale AL, Gatti RA, Concannon P, Haile RW. ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer. Br J Cancer. 2003 Oct 20; 89(8):1513-6.
      View in: PubMed
    54. Bernstein JL, Teraoka S, Haile RW, Børresen-Dale AL, Rosenstein BS, Gatti RA, Diep AT, Jansen L, Atencio DP, Olsen JH, Bernstein L, Teitelbaum SL, Thompson WD, Concannon P. Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. Hum Mutat. 2003 May; 21(5):542-50.
      View in: PubMed
    55. Zeman EM, Dynlacht JR, Rosenstein BS, Dewhirst MW. Toward a national consensus: teaching radiobiology to radiation oncology residents. Int J Radiat Oncol Biol Phys. 2002 Nov 1; 54(3):861-72.
      View in: PubMed
    56. Dynlacht JR, Dewhirst MW, Hall EJ, Rosenstein BS, Zeman EM. Toward a consensus on radiobiology teaching to radiation oncology residents. Radiat Res. 2002 May; 157(5):599-606.
      View in: PubMed
    57. Iannuzzi CM, Atencio DP, Green S, Stock RG, Rosenstein BS. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys. 2002 Mar 1; 52(3):606-13.
      View in: PubMed
    58. Formenti SC, Rosenstein B, Skinner KA, Jozsef G. T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients--pilot feasibility study. Radiology. 2002 Jan; 222(1):171-8.
      View in: PubMed
    59. Cho SG, Bhoumik A, Broday L, Ivanov V, Rosenstein B, Ronai Z. TIP49b, a regulator of activating transcription factor 2 response to stress and DNA damage. Mol Cell Biol. 2001 Dec; 21(24):8398-413.
      View in: PubMed
    60. Atencio DP, Iannuzzi CM, Green S, Stock RG, Bernstein JL, Rosenstein BS. Screening breast cancer patients for ATM mutations and polymorphisms by using denaturing high-performance liquid chromatography. Environ Mol Mutagen. 2001; 38(2-3):200-8.
      View in: PubMed
    61. Drumea KC, Levine E, Bernstein J, Shank B, Green S, Kaplan E, Mandell L, Cropley J, Obropta J, Braccia I, Krupnik A, Rosenstein BS. ATM heterozygosity and breast cancer: screening of 37 breast cancer patients for ATM mutations using a non-isotopic RNase cleavage-based assay. Breast Cancer Res Treat. 2000 May; 61(1):79-85.
      View in: PubMed
    62. Rosenstein BS, Phelps RG, Weinstock MA, Bernstein JL, Gordon ML, Rudikoff D, Kantor I, Shelton R, Lebwohl MG. p53 mutations in basal cell carcinomas arising in routine users of sunscreens. Photochem Photobiol. 1999 Nov; 70(5):798-806.
      View in: PubMed
    63. Rosenstein BS, Weinstock MA, Habib R. Transmittance spectra and theoretical sun protection factors for a series of sunscreen-containing sun care products. Photodermatol Photoimmunol Photomed. 1999 Apr; 15(2):75-80.
      View in: PubMed
    64. Wang Y, Rosenstein B, Goldwyn S, Zhang X, Lebwohl M, Wei H. Differential regulation of P53 and Bcl-2 expression by ultraviolet A and B. J Invest Dermatol. 1998 Sep; 111(3):380-4.
      View in: PubMed
    65. Liu Z, Lu Y, Rosenstein B, Lebwohl M, Wei H. Benzo[a]pyrene enhances the formation of 8-hydroxy-2'-deoxyguanosine by ultraviolet A radiation in calf thymus DNA and human epidermoid carcinoma cells. Biochemistry. 1998 Jul 14; 37(28):10307-12.
      View in: PubMed
    66. Subramanian D, Rosenstein BS, Muller MT. Ultraviolet-induced DNA damage stimulates topoisomerase I-DNA complex formation in vivo: possible relationship with DNA repair. Cancer Res. 1998 Mar 1; 58(5):976-84.
      View in: PubMed
    67. Rosenstein BS, Subramanian D, Muller MT. The involvement of topoisomerase I in the induction of DNA-protein crosslinks and DNA single-strand breaks in cells of ultraviolet-irradiated human and frog cell lines. Radiat Res. 1997 Dec; 148(6):575-9.
      View in: PubMed
    68. Zhang X, Rosenstein BS, Wang Y, Lebwohl M, Mitchell DM, Wei H. Induction of 8-oxo-7,8-dihydro-2'-deoxyguanosine by ultraviolet radiation in calf thymus DNA and HeLa cells. Photochem Photobiol. 1997 Jan; 65(1):119-24.
      View in: PubMed
    69. Zhang X, Rosenstein BS, Wang Y, Lebwohl M, Wei H. Identification of possible reactive oxygen species involved in ultraviolet radiation-induced oxidative DNA damage. Free Radic Biol Med. 1997; 23(7):980-5.
      View in: PubMed
    70. Flotte T, Carter B, Conrad C, Guggino W, Reynolds T, Rosenstein B, Taylor G, Walden S, Wetzel R. A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum Gene Ther. 1996 Jun 10; 7(9):1145-59.
      View in: PubMed
    71. Rosenstein BS, Vaslet CA. Molecular cloning of the human gene SUVCC3 associated with the formation of DNA-protein crosslinks following exposure to solar UV radiation. Somat Cell Mol Genet. 1995 Jul; 21(4):255-63.
      View in: PubMed
    72. Rosenstein BS, Vaslet CA. Molecular cloning of the human gene SUVCC2 associated with mutagenesis following the induction of non-dimer DNA damages by solar UV radiation. J Photochem Photobiol B. 1995 Jun; 28(3):203-11.
      View in: PubMed
    73. Rosenstein BS, Vaslet CA, Rosenstein RB. Molecular cloning of the human gene SUVCC1 associated with the repair of nondimer DNA damage induced by solar UV radiation. Photochem Photobiol. 1995 Feb; 61(2):142-8.
      View in: PubMed
    74. Rosenstein BS, Rosenstein RB. Survival, excision repair and inhibition of DNA synthesis in normal human skin fibroblasts exposed to simulated sunlight. J Photochem Photobiol B. 1992 Dec; 16(3-4):247-55.
      View in: PubMed
    75. Rosenstein BS, Rosenstein RB, Zamansky GB. Repair of DNA damage induced in systemic lupus erythematosus skin fibroblasts by simulated sunlight. J Invest Dermatol. 1992 Apr; 98(4):469-74.
      View in: PubMed
    76. Rosenstein BS, Mitchell DL. The repair of DNA damages induced in normal human skin fibroblasts exposed to simulated sunlight. Radiat Res. 1991 Jun; 126(3):338-42.
      View in: PubMed
    77. Lai LW, Rosenstein BS. Induction of DNA strand breaks and DNA-protein cross-links in normal human skin fibroblasts following exposure to 254 nm UV radiation. J Photochem Photobiol B. 1990 Aug; 6(4):395-404.
      View in: PubMed
    78. Rosenstein BS. Inhibition and recovery of semiconservative DNA synthesis in normal and solar UV sensitive ICR 2A frog cell lines following the induction of non-dimer DNA damage by sunlamp UV greater than 315 nm. Int J Radiat Biol. 1989 Aug; 56(2):131-8.
      View in: PubMed
    79. Rosenstein BS, Lai LW, Ducore JM, Rosenstein RB. DNA-protein crosslinking in normal and solar UV-sensitive ICR 2A frog cell lines exposed to solar UV-radiation. Mutat Res. 1989 May; 217(3):219-26.
      View in: PubMed
    80. Rosenstein BS. DNA strand breakage in normal and solar ultraviolet-sensitive ICR 2A frog cell lines exposed to solar ultraviolet wavelengths. Environ Mol Mutagen. 1989; 13(1):50-3.
      View in: PubMed
    81. Rosenstein BS. Analysis of a photosensitive lesion induced by sunlamp UV greater than 315 nm exposure of 254-nm-irradiated human cells. J Photochem Photobiol B. 1988 Nov; 2(3):381-7.
      View in: PubMed
    82. Rosenstein BS. The induction of DNA strand breaks in normal human skin fibroblasts exposed to solar ultraviolet radiation. Radiat Res. 1988 Nov; 116(2):313-9.
      View in: PubMed
    83. Lai LW, Ducore JM, Rosenstein BS. DNA-protein crosslinking in normal human skin fibroblasts exposed to solar ultraviolet wavelengths. Photochem Photobiol. 1987 Jul; 46(1):143-6.
      View in: PubMed
    84. Rosenstein BS, Mitchell DL. Action spectra for the induction of pyrimidine(6-4)pyrimidone photoproducts and cyclobutane pyrimidine dimers in normal human skin fibroblasts. Photochem Photobiol. 1987 Jun; 45(6):775-80.
      View in: PubMed
    85. Mitchell DL, Rosenstein BS. The use of specific radioimmunoassay to determine action spectra for the photolysis of (6-4) photoproducts. Photochem Photobiol. 1987 Jun; 45(6):781-6.
      View in: PubMed
    86. Mitchell DL, Clarkson JM, Chao CC, Rosenstein BS. Repair of cyclobutane dimers and (6-4) photoproducts in ICR 2A frog cells. Photochem Photobiol. 1986 May; 43(5):595-7.
      View in: PubMed
    87. Chao CC, Rosenstein BS. Use of metabolic inhibitors to investigate the excision repair of pyrimidine dimers and non-dimer DNA damages induced in human and ICR 2A frog cells by solar ultraviolet radiation. Photochem Photobiol. 1986 Feb; 43(2):165-70.
      View in: PubMed
    88. Rosenstein BS, Chao CC, Ducore JM. The use of metabolic inhibitors to compare the excision repair of pyrimidine dimers and nondimer DNA damages in human skin fibroblasts exposed to 254-nm and sunlamp-produced greater than 310-nm ultraviolet radiation. Environ Mutagen. 1986; 8(3):335-43.
      View in: PubMed
    89. Rosenstein BS, Murphy JT, Ducore JM. Use of a highly sensitive assay to analyze the excision repair of dimer and nondimer DNA damages induced in human skin fibroblasts by 254-nm and solar ultraviolet radiation. Cancer Res. 1985 Nov; 45(11 Pt 1):5526-31.
      View in: PubMed
    90. Rosenstein BS, Chao CC. Characterization of DNA repair in a mutant cell line derived from ICR 2A frog cells that is hypersensitive to non-dimer DNA damages induced by solar ultraviolet radiation. Mutat Res. 1985 Sep; 146(2):191-6.
      View in: PubMed
    91. Rosenstein BS, Chao CC, Ducore JM. Analysis of the excision repair of nondimer DNA damage induced by solar ultraviolet radiation in ICR 2A frog cells. Radiat Res. 1985 Aug; 103(2):286-92.
      View in: PubMed
    92. Rosenstein BS, Chao CC. Isolation of a mutant cell line derived from ICR 2A frog cells hypersensitive to the induction of non-dimer DNA damage by solar ultraviolet radiation. Somat Cell Mol Genet. 1985 Jul; 11(4):339-44.
      View in: PubMed
    93. Ducore JM, Rosenstein BS. Theophylline release of replicon initiation inhibition by nitrosoureas correlates with the synergistic killing in L1210 leukemia in vitro. Mutat Res. 1985 Jul; 146(1):1-8.
      View in: PubMed
    94. Chao CC, Rosenstein BS. Induction of sister-chromatid exchanges in ICR 2A frog cells exposed to 254 nm and solar UV wavelengths. Photochem Photobiol. 1985 May; 41(5):625-7.
      View in: PubMed
    95. Chao CC, Rosenstein RB, Rosenstein BS. Induction of sister-chromatid exchanges in ICR 2A frog cells exposed to 265-313 nm monochromatic ultraviolet wavelengths and photoreactivating light. Mutat Res. 1985 May; 149(3):443-50.
      View in: PubMed
    96. Rosenstein BS. Kinetics of the inhibition and recovery of semiconservative DNA synthesis following the induction of non-dimer DNA damages by solar ultraviolet radiation in ICR 2A frog cells. Environ Mutagen. 1985; 7(6):913-8.
      View in: PubMed
    97. Rosenstein BS, Rosenstein RB. Induction of chromosome aberrations in ICR 2A frog cells exposed to 265-313 nm monochromatic ultraviolet wavelengths and photoreactivating light. Photochem Photobiol. 1985 Jan; 41(1):57-61.
      View in: PubMed
    98. Rosenstein BS. Inhibition of semiconservative DNA synthesis in ICR 2A frog cells by pyrimidine dimers and nondimer photoproducts induced by ultraviolet radiation. Radiat Res. 1984 Nov; 100(2):378-86.
      View in: PubMed
    99. Ducore JM, Rosenstein BS. Theophylline reversal of alkylator-induced replicon initiation inhibition: no correlation with DDP-induced cytotoxicity. Mutat Res. 1984 Oct; 141(2):117-21.
      View in: PubMed
    100. Ducore JM, Rosenstein BS. Theophylline does not reverse DNA replicon initiation inhibition in human cells resistant to alkylating agent-theophylline killing synergism. Chem Biol Interact. 1984 Sep 15; 51(2):191-200.
      View in: PubMed
    101. Rosenstein BS. Photoreactivation of ICR 2A frog cells exposed to solar UV wavelengths. Photochem Photobiol. 1984 Aug; 40(2):207-13.
      View in: PubMed
    102. Rosenstein BS. Mitotic inhibition of ICR 2A frog cells exposed to 265-313 nm monochromatic ultraviolet wavelengths and photoreactivating light. Int J Radiat Biol Relat Stud Phys Chem Med. 1984 Jan; 45(1):85-91.
      View in: PubMed
    103. Rosenstein BS, Ducore JM. Enhancement by bilirubin of DNA damage induced in human cells exposed to phototherapy light. Pediatr Res. 1984 Jan; 18(1):3-6.
      View in: PubMed
    104. Chao CC, Rosenstein BS. Inhibition of the UV induction of sister-chromatid exchanges in ICR-2A frog cells by pretreatment with gamma-rays. Mutat Res. 1984 Jan; 139(1):35-9.
      View in: PubMed
    105. Rosenstein BS, Ducore JM, Cummings SW. The mechanism of bilirubin-photosensitized DNA strand breakage in human cells exposed to phototherapy light. Mutat Res. 1983 Dec; 112(6):397-406.
      View in: PubMed
    106. Rosenstein BS, Ducore JM. Induction of DNA strand breaks in normal human fibroblasts exposed to monochromatic ultraviolet and visible wavelengths in the 240-546 nm range. Photochem Photobiol. 1983 Jul; 38(1):51-5.
      View in: PubMed
    107. Rosenstein BS. Inhibition of semiconservative DNA synthesis in ICR 2A frog cells exposed to monochromatic uv wavelengths (252-313 nm) and photoreactivating light. Radiat Res. 1982 Jun; 90(3):509-17.
      View in: PubMed
    108. Rosenstein BS. The action spectra for photoreactivation and photorepair in ICR 2A frog cells. Photochem Photobiol. 1982 Apr; 35(4):491-4.
      View in: PubMed
    109. Rosenstein BS. The action spectrum (313-435 nm) for killing Hoechst 33258 treated Chinese hamster ovary cells containing bromodeoxyuridine substituted DNA. Photochem Photobiol. 1982 Feb; 35(2):163-6.
      View in: PubMed
    110. Yarosh DB, Rosenstein BS, Setlow RB. Excision repair and patch size in UV-irradiated bacteriophage T4. J Virol. 1981 Nov; 40(2):465-71.
      View in: PubMed
    111. Rosenstein BS, Kantor GJ. Photoreactivation of ultraviolet irradiated non-dividing populations of ICR 2A frog cells. Photochem Photobiol. 1981 Jan; 33(1):85-9.
      View in: PubMed
    112. Rosenstein BS, Setlow RB. Photoreactivation of ICR 2A frog cells after exposure to monochromatic ultraviolet radiation in the 252-313 nm range. Photochem Photobiol. 1980 Sep; 32(3):361-6.
      View in: PubMed
    113. Rosenstein BS, Setlow RB. DNA repair after ultraviolet irradiation of ICR 2A frog cells. Pyrimidine dimers are long acting blocks to nascent DNA synthesis. Biophys J. 1980 Aug; 31(2):195-205.
      View in: PubMed
    114. Ahmed FE, Gentil A, Rosenstein BS, Setlow RB. DNA excision repair in human cells treated with ultraviolet radiation and 7,12-dimethylbenz[a]anthracene 5,6-oxide. Biochim Biophys Acta. 1980 Jun 27; 608(1):154-66.
      View in: PubMed
    115. Rosenstein BS, Setlow RB, Ahmed FE. Use of the dye Hoechst 33258 in a modification of the bromodeoxyuridine photolysis technique for the analysis of DNA repair. Photochem Photobiol. 1980 Mar; 31(3):215-22.
      View in: PubMed
    116. Rosenstein B, Ohlsson-Wilhelm BM. Isolation of UV-sensitive clones from a haploid frog cell line. Somatic Cell Genet. 1979 Jan; 5(1):117-28.
      View in: PubMed
    117. Rosenstein BS, Ohlsson-Wilhelm BM. Transfer of genetic information via isolated amphibian metaphase chromosomes. Somatic Cell Genet. 1978 May; 4(3):341-54.
      View in: PubMed
    Rosenstein's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067